VALIDATING AN INDUSTRY-SPONSORED MODEL COMPARING THE COST-EFFECTIVENESS OF ATYPICAL ANTIPSYCHOTICS IN THE TREATMENT OF SCHIZOPHRENIA

被引：0
|
作者：
Graham, Christopher N. [1 ]
Mauskopf, Josephine [1 ]
Lawson, Anthony H. [2 ]
Ascher-Svanum, Haya [2 ]
Bruhn, David [2 ]
Watson, Peter R. [2 ]
机构：
[1] RTI Hlth Solut Res, Res Triangle Pk, NC USA
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
SCHIZOPHRENIA RESEARCH | 2010年 / 117卷 / 2-3期
关键词：
D O I：
10.1016/j.schres.2010.02.722
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：398 / 399
页数：2
相关论文
共 50 条
  • [31] COST-EFFECTIVENESS OF ANTIPSYCHOTICS FOR THE TREATMENT OF RELAPSE PREVENTION FOR SCHIZOPHRENIA. THE SPANISH PERSPECTIVE
    Garcia-Agua Soler, N.
    Garcia-Ruiz, A. J.
    Martos-Crespo, F.
    Perez-Costillas, L.
    Alcalde de Hoyos, J.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 70 - 70
  • [32] Methods of cost-effectiveness analysis in the evaluation of new antipsychotics: Implications for schizophrenia treatment
    Neumann, PJ
    JOURNAL OF CLINICAL PSYCHIATRY, 1999, 60 : 9 - 15
  • [33] Cost-effectiveness of Paliperidone Palmitate Versus other Antipsychotics for the Treatment of Schizophrenia in France
    Doutriaux, A.
    Druais, S.
    Cognet, M.
    Lancon, C.
    Samalin, L.
    Levy, P.
    Godet, A.
    Guillon, P.
    JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 2015, 18 : S11 - S12
  • [34] Cost-effectiveness in the treatment of schizophrenia
    Knapp, MRJ
    EUROPEAN PSYCHIATRY, 1996, 11 (03) : 137 - 143
  • [35] Atypical antipsychotics in the treatment of schizophrenia - Cost is a crucial issue
    Duggins, R
    Rhinds, D
    Hall, W
    BRITISH MEDICAL JOURNAL, 2001, 322 (7291): : 926 - 926
  • [36] Cost-effectiveness of atypical Antipsychotics in the CATIE Alzheimers disease trial
    Rosenheck, RA
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S42 - S43
  • [37] COST-EFFECTIVENESS OF ATYPICAL ANTIPSYCHOTICS FOR THE TREATMENT OF RELAPSE PREVENTION FOR BIPOLAR DISORDER: THE RUSSIAN PERSPECTIVE
    Kulikov, A.
    Komarov, I
    VALUE IN HEALTH, 2013, 16 (03) : A62 - A62
  • [38] Cost-Effectiveness of Adjunctive Therapy with Atypical Antipsychotics for Acute Treatment of Major Depressive Disorder
    Taneja, Charu
    Papakostas, George I.
    Jing, Yonghua
    Baker, Ross A.
    Forbes, Robert A.
    Oster, Gerry
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (05) : 642 - 649
  • [39] ANALYSIS OF COST EFFECTIVENESS OF ATYPICAL ANTIPSYCHOTICS IN THE TREATMENT OF SCHIZOPHRENIA BASED ON NNT (NUMBER NEEDED TREAT)
    Pereira, M.
    Duchesne, I
    VALUE IN HEALTH, 2009, 12 (07) : A521 - A521
  • [40] COST-EFFECTIVENESS IN THE TREATMENT OF PATIENTS WITH SCHIZOPHRENIA
    GOLDBERG, D
    ACTA PSYCHIATRICA SCANDINAVICA, 1994, 89 : 89 - 92
12345